Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing

Multiple platforms are commercially available for the detection of circulating cell-free tumour DNA (ctDNA) from liquid biopsies. Since platforms have different input and output variables, deciding what platform to use for a given clinical or research question can be daunting. This study aimed to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vessies, D. C. L., Greuter, M. J. E., van Rooijen, K. L., Linders, T. C., Lanfermeijer, M., Ramkisoensing, K. L., Meijer, G. A., Koopman, M., Coupé, V. M. H., Vink, G. R., Fijneman, R. J. A., van den Broek, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229219/
https://www.ncbi.nlm.nih.gov/pubmed/32415199
http://dx.doi.org/10.1038/s41598-020-64822-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229219/
https://www.ncbi.nlm.nih.gov/pubmed/32415199
http://dx.doi.org/10.1038/s41598-020-64822-7

Ejemplares similares